Brazil's Chancellor, Luis Felipe Lampreira, has added an extra clause to the country's proposed new patent legislation, providing for the one-time patenting of transgenic micro-organisms. This is not covered by the agreement on Trade Related Aspects of Intellectual Property Rights.
However, the Chancellor commented that nobody can guarantee when the new law would be approved, and this is a problem, he said. During April, the Senate's Constitutional and Justice Commission twice postponed a vote on the legislation, even though the country's President, Fernando Henrique Cardoso, assured US President Bill Clinton, during a visit to the USA, that the passage of an intellectual property law that would satisfy US requirements was close.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze